Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Aug;24(9):1287-93.
doi: 10.1038/ejhg.2016.26. Epub 2016 Apr 6.

A novel kinase mutation in VEGFR-1 predisposes its αC-helix/activation loop towards allosteric activation: Atomic insights from protein simulation

Affiliations

A novel kinase mutation in VEGFR-1 predisposes its αC-helix/activation loop towards allosteric activation: Atomic insights from protein simulation

Taseem A Mokhdomi et al. Eur J Hum Genet. 2016 Aug.

Abstract

Vascular endothelial growth factor receptor 1 (VEGFR-1) has been implicated in diverse pathologies, including cancers. Although VEGFR-1 is considered as functionally impaired kinase, its decoy characteristics make it an important regulator of VEGFR-mediated signaling, particularly in tumor angiogenesis. VEGFR-1 conveys signaling via its tyrosine kinase (TK) domain whose activation is regulated by phosphorylation of specific tyrosine residues. Thus dysregulation of VEGFR-1 signaling, as reported in most of the cancers, might be a consequence of altered phosphorylation that could be attributed to genotypic variations in its TK domain. Considering the importance of TK domain of VEGFR-1, we carried out its mutational screening in 84 clinically validated and histopathologically confirmed colorectal cancer patients. By means of direct DNA sequencing and SNP analyses, eight novel variations, including one synonymous, two deletion, one missense and four intronic variations, were reported in the TK domain of VEGFR-1. rs730882263:C>G variation specifically reported in colon cancer, representing a single-atomic change (Sulfur to Oxygen) in the predicted (p.Cys1110Ser) protein, was observed as potentially deleterious variation as assessed by multiple single-nucleotide polymorphism prediction servers. Molecular dynamics simulations of VEGFR-1 Wt and (p.Cys1110Ser) variant models revealed major conformational changes in variant protein presumptuously generating an open conformation thereby exposing the activation domain and consequently increasing the probability of phosphorylation events: a condition frequently reported in cancers.

PubMed Disclaimer

Figures

Figure 1
Figure 1
MD simulations of wild-type (black) and variant (red) structures. (a) RMSD plot depicting time points having maximal variation in structures between wild-type and variant structures captured during protein simulation at (I) 13.462, (II) 15.694, (III) 24.730 and (IV) 47.700 ns. (b) Comparative RMSF plot showing fluctuations in wild-type (black) and variant (red) structures along the protein stretch together with their predicted secondary structures. Functionally important positions are highlighted in color. A full color version of this figure is available at the European Journal of Human Genetics journal online.
Figure 2
Figure 2
Graph depicting relative trend in (a) surface area and (b) radius of gyration (Rg) of wild-type (black) and variant (red) during 50 ns MD simulation. A full color version of this figure is available at the European Journal of Human Genetics journal online.
Figure 3
Figure 3
Structure of tyrosine kinase domain of VEGFR-1 depicting important regions in its catalytic core. Prepared from PDB file 3HNGA using Accelrys Discovery Studio 4.1. A full color version of this figure is available at the European Journal of Human Genetics journal online.
Figure 4
Figure 4
Molecular docking simulation with ATP/ADP at binding sites in the catalytic pocket of VEGF receptors showing differential binding energy pattern in tyrosine phosphorylation events*. (*Based upon ligand docking with ATP or ADP; VEGFR-2 has been shown for comparison). A full color version of this figure is available at the European Journal of Human Genetics journal online.
Figure 5
Figure 5
Comparison of distance spanning through the motifs of wild-type and variant tyrosine kinase domain of VEGFR-1. (a) The distance between Glycine-rich loop (green) and catalytic loop (yellow) was shortened owing to the closure of glycine loop in the variant structure; however, (b) there was no change in distance between glycine-rich loop (green) and αC-helix (brown). (c) Widening of catalytic pocket wherein the distance between the activation segment (orange) and αC-helix (brown) is significantly increased to 27.140 and 28.096 Å from the positioned Lys 861 (αC-helix) to Tyr1048 and Tyr1053 (activation loop), respectively. A full color version of this figure is available at the European Journal of Human Genetics journal online.

Similar articles

Cited by

References

    1. Shibuya M: Role of Vegf-Flt receptor system in normal and tumor angiogenesis. Adv Cancer Res 1995; 281–316. - PubMed
    1. Dvorak HF: Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J Clin Oncol 2002; 20: 4368–4380. - PubMed
    1. Li Y: Active immunization against the vascular endothelial growth factor receptor flk1 inhibits tumor angiogenesis and metastasis. J Exp Med 2002; 195: 1575–1584. - PMC - PubMed
    1. Yoshimura K, Minami T, Nozawa M, Uemura H: Phase I clinical trial of human vascular endothelial growth factor receptor 1 peptide vaccines for patients with metastatic renal cell carcinoma. Br J Cancer 2013; 108: 1260–1266. - PMC - PubMed
    1. Shen L, Zhou Q, Wang Y et al: Antiangiogenic and antitumoral effects mediated by a vascular endothelial growth factor receptor 1 (VEGFR-1)-targeted DNAzyme. Mol Med 2013; 19: 377–386. - PMC - PubMed

MeSH terms

Substances